amphetamine and aripiprazole

amphetamine has been researched along with aripiprazole in 13 studies

Research

Studies (13)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	7 (53.85)	29.6817
2010's	5 (38.46)	24.3611
2020's	1 (7.69)	2.80

Authors

Authors	Studies
Lombardo, F; Obach, RS; Waters, NJ	1
Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC	1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K	1
Clarke, K; Davies, CH; Forbes, IT; Gribble, A; Hill, M; Jones, DN; Newson, M; Reavill, C; Rourke, C; Scott, C; Westaway, J; Wood, MD	1
Koch, M; Schwabe, K	1
Föhr, J; Haukka, J; Kuikanmäki, O; Kuoppasalmi, K; Meririnne, E; Sokero, P; Tiihonen, J; Tuomola, P; Vorma, H	1
Guimarães, FS; Leite, JV; Moreira, FA	1
Jerlhag, E	1
Shen, YC	1
Avenet, P; Bergis, O; Boulay, D; Griebel, G	1
Ahlbrand, R; Bronson, SL; Grainger, M; Horn, P; McNamara, RK; Richtand, NM; Tambyraja, R	1
Abdoli, N; Aghaei, A; Bajoghli, H; Brand, S; Farnia, V; Juibari, TA; Shakeri, J; Tatari, F; Yazdchi, K	1
Juza, R; Kelemen, E; Korabecny, J; Petrasek, T; Soukup, O; Stuchlik, A; Tuckova, K; Vojtechova, I	1

Reviews

1 review(s) available for amphetamine and aripiprazole

Article	Year
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug discovery today, 2016, Volume: 21, Issue:4 Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk	2016

Trials

2 trial(s) available for amphetamine and aripiprazole

Article	Year
A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence. The American journal of psychiatry, 2007, Volume: 164, Issue:1 Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Aripiprazole; Female; Humans; Male; Methylphenidate; Piperazines; Placebos; Quinolones; Severity of Illness Index; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome	2007
Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis. The American journal of drug and alcohol abuse, 2014, Volume: 40, Issue:1 Topics: Adolescent; Adult; Amphetamine; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Quinolones; Risperidone; Symptom Assessment; Treatment Outcome; Young Adult	2014

Article

Year

A comparison of aripiprazole, methylphenidate, and placebo for amphetamine dependence.

The American journal of psychiatry, 2007, Volume: 164, Issue:1

Topics: Adult; Amphetamine; Amphetamine-Related Disorders; Aripiprazole; Female; Humans; Male; Methylphenidate; Piperazines; Placebos; Quinolones; Severity of Illness Index; Substance Abuse Detection; Substance Abuse, Intravenous; Treatment Outcome

2007

Randomized controlled trial of aripiprazole versus risperidone for the treatment of amphetamine-induced psychosis.

The American journal of drug and alcohol abuse, 2014, Volume: 40, Issue:1

Topics: Adolescent; Adult; Amphetamine; Antipsychotic Agents; Aripiprazole; Double-Blind Method; Female; Humans; Male; Middle Aged; Piperazines; Psychoses, Substance-Induced; Quinolones; Risperidone; Symptom Assessment; Treatment Outcome; Young Adult

2014

Other Studies

10 other study(ies) available for amphetamine and aripiprazole

Article	Year
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds. Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7 Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding	2008
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate. Bioorganic & medicinal chemistry letters, 2010, Dec-15, Volume: 20, Issue:24 Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility	2010
Aripiprazole and its human metabolite are partial agonists at the human dopamine D2 receptor, but the rodent metabolite displays antagonist properties. European journal of pharmacology, 2006, Sep-28, Volume: 546, Issue:1-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Binding, Competitive; Biotransformation; Catalepsy; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; Dyskinesia, Drug-Induced; Guanosine 5'-O-(3-Thiotriphosphate); HeLa Cells; Humans; Male; Motor Activity; Oxidopamine; Piperazines; Quinolones; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D2; Species Specificity; Transfection	2006
Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats. Psychopharmacology, 2007, Volume: 191, Issue:3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Behavior, Animal; Central Nervous System Stimulants; Conditioning, Operant; Dopamine Agents; Dose-Response Relationship, Drug; Male; Motivation; Piperazines; Quinolones; Rats; Rats, Wistar; Reinforcement Schedule; Reward; Substance Withdrawal Syndrome	2007
Aripiprazole, an atypical antipsychotic, prevents the motor hyperactivity induced by psychotomimetics and psychostimulants in mice. European journal of pharmacology, 2008, Jan-14, Volume: 578, Issue:2-3 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Central Nervous System Stimulants; Cocaine; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Partial Agonism; Excitatory Amino Acid Antagonists; Glutamine; Haloperidol; Hyperkinesis; Ketamine; Locomotion; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2; Receptors, N-Methyl-D-Aspartate; Time Factors	2008
The antipsychotic aripiprazole antagonizes the ethanol- and amphetamine-induced locomotor stimulation in mice. Alcohol (Fayetteville, N.Y.), 2008, Volume: 42, Issue:2 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Ethanol; Male; Mice; Motor Activity; Piperazines; Quinolones; Receptors, Dopamine D2	2008
Amphetamine as a risk factor for aripiprazole-induced acute dystonia. Progress in neuro-psychopharmacology & biological psychiatry, 2008, Oct-01, Volume: 32, Issue:7 Topics: Acute Disease; Adult; Amphetamine; Aripiprazole; Dystonia; Humans; Male; Piperazines; Quinolones; Risk Factors	2008
The glycine transporter-1 inhibitor SSR103800 displays a selective and specific antipsychotic-like profile in normal and transgenic mice. Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2010, Volume: 35, Issue:2 Topics: Amphetamine; Analysis of Variance; Animals; Antipsychotic Agents; Aripiprazole; Catalepsy; Clozapine; Disease Models, Animal; Dizocilpine Maleate; Dopamine Plasma Membrane Transport Proteins; Glycine Plasma Membrane Transport Proteins; Hyperkinesis; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Motor Activity; Piperazines; Quinolones; Receptors, N-Methyl-D-Aspartate	2010
Fluoxetine and aripiprazole treatment following prenatal immune activation exert longstanding effects on rat locomotor response. Physiology & behavior, 2012, May-15, Volume: 106, Issue:2 Topics: Acute-Phase Reaction; Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Disease Models, Animal; Dose-Response Relationship, Drug; Female; Fluoxetine; Immune System; Male; Motor Activity; Piperazines; Poly I-C; Pregnancy; Prenatal Exposure Delayed Effects; Quinolones; Rats; Rats, Sprague-Dawley; Schizophrenia; Selective Serotonin Reuptake Inhibitors	2012
Dopaminergic and glutamatergic models of psychosis show differential sensitivity to aripiprazole and a novel experimental compound modulating D Progress in neuro-psychopharmacology & biological psychiatry, 2023, 12-20, Volume: 127 Topics: Amphetamine; Animals; Antipsychotic Agents; Aripiprazole; Dizocilpine Maleate; Dopamine; Dose-Response Relationship, Drug; Psychotic Disorders; Quinolones; Rats; Receptors, Serotonin	2023